Abel Hall LLC’s CME Group CME Stock Holding History

Abel Hall LLC’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,131	Closed	-$334K	–	989
2026 Q1	$334K	Buy	+1,131	New	+$336K	0.07%	353
2025 Q3	–	Sell	-924	Closed	-$255K	–	333
2025 Q2	$255K	Buy	924 +98	+12%	+$26.6K	0.12%	187
2025 Q1	$219K	Buy	+826	New	+$204K	0.13%	153

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Abel Hall LLC's CME Position: Q2 2026 in Review

Abel Hall LLC sold out of CME Group (CME) in Q2 2026, closing a stake of 1,131 shares — an estimated $334K sold.

Abel Hall LLC first reported a position in CME in Q1 2025 and held it in 3 quarters. The position peaked at $334K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Abel Hall LLC reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Abel Hall LLC sold 1,131 CME Group shares in Q2 2026, an estimated $334K.
Abel Hall LLC first reported a position in CME Group in Q1 2025 and held it in 3 quarters.
Abel Hall LLC's CME Group position peaked at $334K in Q1 2026.
1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.